Similar articles

• [Influence of diabetes mellitus on the initial and long-term outcome of patients treated with coronary stenting].

  Tanigawa T, Ishiwata S, Yamamoto T, Fujimoto Y, Nameki M, Koizumi T, Iwase T, Nishiyama S, Nakanishi S, Momomura S. Tanigawa T, et al. J Cardiol. 2002 Mar;39(3):133-40. J Cardiol. 2002. PMID: 11912947 Japanese.
• Coronary revascularisation in the patient with diabetes: balancing risk and benefit.

  Rutter MK, Nesto RW. Rutter MK, et al. Heart. 2010 Sep;96(18):1436-40. doi: 10.1136/hrt.2010.201541. Heart. 2010. PMID: 20813726 Review. No abstract available.
• Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials.

  Kirtane AJ, Ellis SG, Dawkins KD, Colombo A, Grube E, Popma JJ, Fahy M, Leon MB, Moses JW, Mehran R, Stone GW. Kirtane AJ, et al. J Am Coll Cardiol. 2008 Feb 19;51(7):708-15. doi: 10.1016/j.jacc.2007.10.035. J Am Coll Cardiol. 2008. PMID: 18279734
• [Comparative study of coronary angioplasty in diabetic patients. Immediate clinical and angiographic results and clinical evolution in the first year of follow up].

  Dussaillant G, Pacheco C, Ramírez A, Ugalde H, Antibilo S, Silva AM, Farías E, Oyonarte M. Dussaillant G, et al. Rev Med Chil. 2001 Aug;129(8):861-70. Rev Med Chil. 2001. PMID: 11680959 Spanish.
• [Diabetes mellitus in coronary bypass surgery: risks and chances. Treatment concepts for a particularly challenging group of patients].

  Lauruschkat AH, Ennker J. Lauruschkat AH, et al. Herz. 2008 Apr;33(3):212-21. doi: 10.1007/s00059-008-3114-4. Herz. 2008. PMID: 18568316 Review. German.